Full-Time

Director Quality Risk Management

Posted on 1/10/2025

McKesson

McKesson

Healthcare distribution and logistics services

Enterprise Software
Healthcare

Senior, Expert

Remote in USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Risk Management
Data Analysis
Google Cloud Platform

You match the following McKesson's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s Degree required, Master’s degree preferred
  • Significant experience of 10 years’ preferred in clinical research and quality assurance, with at least 5 years in a leadership role focused on risk management
  • A proven track record of successfully implementing QbD principles in clinical research, including but not limited to protocol derisking and Risk Based Monitoring approaches (RBM)
  • In-depth knowledge of regulatory guidelines (e.g. ICH E6, ICH Q9, guidelines) GCP, and other relevant regulatory requirements.
Responsibilities
  • Develop and implement a comprehensive Quality Risk Management (QRM) all inclusive (CRO, SMO, & QA) strategy aligned with the ICH Q9, ICH E8 and ICH E6 R3, as well as FDA and EMA guidance documents.
  • Establish the QRM framework within the QA department, fostering a culture of risk awareness and continuous improvement.
  • Integrate QbD principles into clinical trial processes to ensure that quality is built into study design and execution from the outset.
  • Facilitate and/or coaching cross-functional teams on understanding and execution of QbD principles and supporting processes, including but not limited to the implementation of protocol de-risking, and Risk Based Monitoring (RBM) approaches.
  • Collaborate with cross-functional teams to ensure that critical to quality factors are proactively identified, analyzed, monitored, and controlled throughout the trial lifecycle.
  • Establish procedures for proactive identification, analyzation, and mitigation strategies for identified risk during a trial set up.
  • Utilize data driven insights to proactively identify potential risks and trends that may impact the quality and integrity of clinical trials during conduct phase.
  • Develop and implement risk mitigation strategies and action plans in collaboration with QA Audit, Training, Quality Governance, Research Operations, and investigator sites.
  • Establish, monitor, and report on KP/RIs aligned with critical to quality factors.
  • Conduct regular reviews and analyses of performance metrics to identify areas for improvement and drive corrective and preventive actions.
  • Research data to establish Key Performance Indicators (KPIs) and Key Risk Indicators (KRIs) aligned with pre-defined critical to quality factors, as well as protocol and trial specific risks.
Desired Qualifications
  • Master’s degree preferred

McKesson Corporation operates in the healthcare sector, focusing on the distribution of medical products and pharmaceuticals. The company acts as a middleman, purchasing medical supplies from manufacturers and delivering them to healthcare providers, pharmacies, and hospitals. This ensures that essential medical products are available when needed, supporting the healthcare system. McKesson generates revenue by marking up the cost of the products they distribute and charging service fees for logistics and supply chain management. They also provide technology solutions to help healthcare providers improve their operations. McKesson's goal is to enhance patient care by ensuring timely access to medical supplies and services through a well-established network and partnerships.

Company Stage

IPO

Total Funding

$7.6M

Headquarters

Irving, Texas

Founded

1833

Simplify Jobs

Simplify's Take

What believers are saying

  • InspiroGene could open new revenue streams in advanced therapies.
  • Investments in data-driven healthcare enhance McKesson's service offerings.
  • Streamlining operations by selling Rexall and Well.ca may improve efficiency.

What critics are saying

  • Closing Rogers center may disrupt local supply chain operations.
  • Selling Rexall and Well.ca could reduce market presence in Canada.
  • InspiroGene may divert focus from core distribution business.

What makes McKesson unique

  • McKesson's InspiroGene focuses on commercializing cell and gene therapies.
  • The company invests in real-world evidence generation through Atropos Health.
  • McKesson supports rural healthcare access with grants for pharmacist training.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

401(k) Company Match

INACTIVE